Activity Description:

Venous thromboembolism (VTE) remains a significant cause of morbidity and mortality, with the development of pulmonary embolism (PE) and deep vein thrombosis (DVT) posing substantial health risks. The evolution of VTE treatment strategies has led to advancements in patient care, including the implementation of PE response teams and tailored DVT management algorithms. Understanding the history, current therapeutic options, and structured protocols for VTE management is essential for optimizing patient outcomes. This activity will explore the etiology, treatment modalities, and strategic responses for VTE, equipping providers with knowledge to improve patient care in this critical area.

Target Audience: 

Attendees may include physicians, nurses, physician assistants, nurse practitioners, medical students, and other medical professionals seeking to expand their knowledge in this field.

Learning Objectives:

• Explain the evolution of Venous Thromboembolism management.
• Analyze current therapies and evidence for pulmonary embolism and deep vein thrombosis.
• Recognize established pulmonary embolism and deep vein thrombosis response protocols.

12.03.24 CV Grand Rounds Flyer.pdf

Moderator:

Emma Fortner

Denise Mathias

Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose with ineligible companies.*

*Ineligible companies – Companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.

Accreditation:

The HCA Healthcare Continental Division is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. 

Credit Designation:

The HCA Healthcare Continental Division designates this live activity for a maximum of 1.0 AMA PRA Category 1^TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Commercial Support:  

This Activity was developed without support from any ineligible company.*The ACCME defines ineligible companies as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Note: The ACCME does not consider providers of clinical service directly to patients to be commercial interests – unless the provider of clinical services is owned, or controlled by, and ACCME defined ineligible company.

Disclosure: 

The HCA Healthcare Continental Division is committed to providing CME that is balanced, objective, and evidenced-based. In accordance with the Accreditation Council for Continuing Medical Education Standards for Integrity and Independence all parties involved in content development are required to disclose all conflicts of interest with ACCME defined ineligible companies. The HCA Healthcare Continental Division has identified, reviewed, and mitigated all conflicts of interest that speakers, authors, course directors, planners, peer reviewers, or relevant staff disclose prior to the delivery of any educational activity. The CME planning committee who are in a position to control the content of this CME Activity, have no relevant financial relationships with ineligible companies to disclose.